F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, announced that it will release earnings for the quarter ending June 30, 2021 before market open on August 12, 2021.
August 2, 2021
· 1 min read